Login / Signup

Graft infusion of adipose-derived mesenchymal stromal cells to prevent rejection in experimental intestinal transplantation: A feasibility study.

Ane M AndresPablo StringaPaloma TalayeroMonica SantamariaMariano García-ArranzSoledad García Gómez-HerasCarlota Largo-AramburuRosa M Aras-LopezMaria Teresa Vallejo-CremadesLaura Guerra PastriánLuz VegaJose Luis EncinasManuel Lopez-SantamariaFrancisco Hernández-Oliveros
Published in: Clinical transplantation (2021)
Ad-MSC did not prevent rejection when administered just before reperfusion. However, they showed immunomodulatory effects that could be relevant for a longer-term outcome. Interference between tacrolimus and the MSC effects should be addressed in further studies.
Keyphrases
  • acute myocardial infarction
  • bone marrow
  • low dose
  • preterm infants
  • atrial fibrillation
  • coronary artery disease
  • brain injury
  • percutaneous coronary intervention
  • case control